Axel Dalhoff

421 total citations
12 papers, 274 citations indexed

About

Axel Dalhoff is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Axel Dalhoff has authored 12 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Pharmacology and 5 papers in Epidemiology. Recurrent topics in Axel Dalhoff's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Urinary Tract Infections Management (3 papers) and Antifungal resistance and susceptibility (3 papers). Axel Dalhoff is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Urinary Tract Infections Management (3 papers) and Antifungal resistance and susceptibility (3 papers). Axel Dalhoff collaborates with scholars based in Germany, Sweden and United Kingdom. Axel Dalhoff's co-authors include Hans Gerd Schiefer, W. Weidner, Stuart B. Levy, Carl Erik Nord, Mamun-Ur Rashid, Andrej Weintraub, Raimund Strehl, S. W. Bender, Hans‐Georg Posselt and Laura J. V. Piddock and has published in prestigious journals such as Clinical Microbiology Reviews, The Journal of Urology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Axel Dalhoff

12 papers receiving 259 citations

Peers

Axel Dalhoff

EPIDE

PHARM

PRM

MM

MB

M. Dan Israel

D. J. Farrell United States

Diletta Pezzani Italy

Anna Silvey Australia

Frederik Boëtius Hertz Denmark

Wei Jia China

Carmen Paz Oplustil Brazil

Angela M. Ristuccia United States

Yuag-Meng Liu Taiwan

Nikolaos A. Triarides United States

M. Dan Israel

Axel Dalhoff

245 ×2.3

EPIDE

59 ×0.7

PHARM

24 ×0.3

PRM

80 ×1.2

MM

48 ×0.9

MB

Citations per year, relative to Axel Dalhoff Axel Dalhoff (= 1×) peers M. Dan

Countries citing papers authored by Axel Dalhoff

Since Specialization

Citations

This map shows the geographic impact of Axel Dalhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Dalhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Dalhoff more than expected).

Fields of papers citing papers by Axel Dalhoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Dalhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Dalhoff. The network helps show where Axel Dalhoff may publish in the future.

Co-authorship network of co-authors of Axel Dalhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Dalhoff. A scholar is included among the top collaborators of Axel Dalhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Dalhoff. Axel Dalhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Dalhoff, Axel. (2017). Does the use of antifungal agents in agriculture and food foster polyene resistance development? A reason for concern. Journal of Global Antimicrobial Resistance. 13. 40–48. 17 indexed citations

2.

Dalhoff, Axel. (2017). For Debate: May the Use of the Polyene Macrolide Natamycin as a Food Additive Foster Emergence of Polyene-Resistance in Candida Species?. Clinical Microbiology Open Access. 6(4). 4 indexed citations

3.

Dalhoff, Axel & Stuart B. Levy. (2015). Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern. International Journal of Antimicrobial Agents. 45(6). 564–567. 32 indexed citations

4.

Rashid, Mamun-Ur, Axel Dalhoff, Andrej Weintraub, & Carl Erik Nord. (2014). In vitro activity of MCB3681 against Clostridium difficile strains. Anaerobe. 28. 216–219. 31 indexed citations

5.

Rashid, Mamun-Ur, Axel Dalhoff, Tobias Bäckström, et al.. (2014). Ecological impact of MCB3837 on the normal human microbiota. International Journal of Antimicrobial Agents. 44(2). 125–130. 25 indexed citations

6.

Dalhoff, Axel. (2014). Pharmacokinetics and Pharmacodynamics of Aerosolized Antibacterial Agents in Chronically Infected Cystic Fibrosis Patients. Clinical Microbiology Reviews. 27(4). 753–782. 46 indexed citations

7.

Döring, Gerd & Axel Dalhoff. (2013). Aerosolised levofloxacin in cystic fibrosis. Expert Opinion on Orphan Drugs. 1(7). 549–556. 3 indexed citations

8.

Piddock, Laura J. V. & Axel Dalhoff. (1993). Should quinolones be used in the treatment of bacterial infections in neutropenic patients?. Journal of Antimicrobial Chemotherapy. 32(5). 771–774. 9 indexed citations

9.

Dalhoff, Axel, et al.. (1987). Penetration of ciprofloxacin into gynecologic tissues.. PubMed. 82(4A). 133–8. 10 indexed citations

10.

Weidner, W., Hans Gerd Schiefer, & Axel Dalhoff. (1987). Therapy of Chronic Bacterial Prostatitis with Ciprofloxacin. The Journal of Urology. 137(6). 1 indexed citations

11.

Weidner, W., Hans Gerd Schiefer, & Axel Dalhoff. (1987). Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study.. PubMed. 82(4A). 280–3. 67 indexed citations

12.

Bender, S. W., et al.. (1986). Ciprofloxacin pharmacokinetics in patients with cystic fibrosis. Infection. 14(1). 17–21. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact